Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Remifentanil on ED95 of Remimazolam for Loss of Consciousness in Adult Patients

NCT05434494 is registered in ClinicalTrials.gov with Ajou University School of Medicine as lead sponsor.

NCT NCT05434494
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05434494 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Remifentanil on ED95 of Remimazolam for Loss of Consciousness in Adult Patients
Lead sponsor
Ajou University School of Medicine
Phase
Not applicable
Overall status
Unknown status
Start date
July 1, 2022
Completion date
August 31, 2023
Enrollment
80 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

remimazolam